EN
HI
Summary
As of 4 Sep, 2026, Lincoln Pharmaceuticals stock price is ₹622.65. During the trading session, the stock has moved between an intraday low of ₹619.00 and an intraday high of ₹627.35. Over the last 52 weeks, Lincoln Pharmaceuticals has traded between ₹440.00 and ₹770.00.
The stock has recorded a trading volume of 22,964 shares, with a market capitalization of ₹20029728. Its Average Traded Price (ATP) is ₹622.46, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 19 @ ₹622.65.
Lincoln Pharmaceuticals has an upper circuit limit of ₹742.00 and a lower circuit limit of ₹494.70. The total value traded stands at ₹1.43 CR, and the delivery percentage for the day is 49.63%.
The stock is currently traded with a market lot size of 1. Lincoln Pharmaceuticals also offers a dividend yield of 0.29%.
Lincoln Pharmaceuticals share price chart
Lincoln Pharmaceuticals Share Key Metrics
Volume
22964.00
Market Cap
1247.15 CR
LTQ@LTP
19@622.65
ATP
622.46
Var Margin
20.59 %
Circuit Range
494.7-742
Delivery %
49.63 %
Value
1.43 CR
ASM/GSM
No
Market Lot
1
Lincoln Pharmaceuticals Fundamentals
P/E Ratio
12.82
P/B Ratio
1.56
Div. Yield
0.29
Sector P/E
41.68
Sector P/B
3.55
Sec. Div. Yield
0.5
Lincoln Pharmaceuticals Resistance and Support
Pivot 617.73
Resistance
First Resistance
630.06
Second Resistance
641.78
Third Resistance
654.11
Support
First Support
606.01
Second Support
593.68
Third Support
581.96
Lincoln Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Sep 03 2026 | 627.35 | 622.65 | 0.70% | 627.35 | 619 |
| Wed Sep 02 2026 | 611.29 | 618.34 | 1.43% | 629.45 | 605.4 |
| Tue Sep 01 2026 | 613 | 609.65 | 0.48% | 613.84 | 604 |
Lincoln Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-28 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Lincoln Pharmaceuticals News
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Outcome for Board Meeting Outcome For Un-Audited Financial Results For The Quarter Ended On June 30, 2026.
Lincoln Pharmaceuticals reported Q1 FY27 consolidated net profit of ₹36.23 cr, up 30.90% YoY, with total income increasing 19.02% to ₹201.55 cr. EBITDA also rose 32.29% to ₹51.70 cr for the quarter. The board recommended an 18% dividend (₹1.80/share) for FY26.
Aug 13 2026 11:37:25
Lincoln Pharmaceuticals Ltd - 531633 - Board Meeting Intimation for Board Meeting Intimation For Consideration And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
Lincoln Pharmaceuticals will hold a board meeting on August 13, 2026. The primary agenda is to consider and approve the un-audited financial results for the first quarter of FY27.
Aug 06 2026 12:37:22
Lincoln Pharmaceuticals Management
| Name | Position |
|---|---|
| Trusha Shah | Company Secretary & Compliance Officer |
| Kishor M Shah | Chairman |
Lincoln Pharmaceuticals Similar Stocks
Q-Line Biotech Ltd.
637.60
18.05 (2.91%)
KMC Speciality Hospitals (India) Ltd.
138.00
4.81 (3.61%)
3B Blackbio Dx Ltd.
1486.20
7.60 (0.51%)
Gujarat Kidney And Super Speciality Ltd.
171.51
3.21 (1.91%)
GPT Healthcare Ltd.
153.68
2.85 (1.89%)
Sigachi Industries Ltd.
32.55
0.02 (0.06%)
Bajaj Healthcare Ltd.
325.20
-3.80 (1.16%)
Unihealth Hospitals Ltd.
719.95
2.35 (0.33%)
Themis Medicare Ltd.
124.87
0.72 (0.58%)
Laxmi Dental Ltd.
199.20
4.62 (2.37%)
Lincoln Pharmaceuticals FAQs
The Buying Price of Lincoln Pharmaceuticals share is 622.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lincoln Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lincoln Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lincoln Pharmaceuticals shares is 12.82. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lincoln Pharmaceuticals shares is 1.56. Useful to assess the stock's value relative to its book value.
To assess Lincoln Pharmaceuticals’s valuation compare Sector P/E, P/B which are 41.68 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lincoln Pharmaceuticals is 1247.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lincoln Pharmaceuticals share price is 770.00 & 440.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lincoln Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
